🠈  Bio Products Laboratories  🠊

Bio Products Laboratory

BPL Plasma is a network of plasma collection centers in the United States. The company is a subsidiary of the UK based Bio Products Laboratory which, in turn, is owned by a Chinese Investment firm named Creat Group.

BPL History

Blood Product Laboratory began in 1954 as part of the British Medical Research Council. In 1991, the National Health Service renamed the division Bio Product Laboratory to emphasize advances in the market.

In 1996 the health service discovered an outbreak of Variant Creutzfeldt–Jakob disease in Edinburgh, Scotland. vCJD is a prion based disease that could infect plasma; So, BPL began sourcing plasma in the United States in 1998.

In 2010, BPL was reorganized as a limited liability company. In 2013 the private equity firm Bain Capital acquired an 80% stake in BPL £230m. In 2016, Bain sold its holdings to a Chinese investment firm named Creat.

profile page

Directory Listings:

References:

Prev ~ ~ Index ~ ~ Next